Cardior: German watchdog approves Novo's acquisition of Cardior Pharmaceuticals
The German cartel office has approved a deal by Denmark's Novo Nordisk (NOVOb.CO), to purchase Cardior Pharmaceuticals, the regulator said in a statement on Thursday.
Read full article »
Cardior is a Germany-based biopharmaceutical company that researches and develops RNA-dependent therapies for the treatment of heart diseases.
Read more